Omega Therapeutics

View the org chart displaying its 22 main executives

Most searched biographies at Omega Therapeutics

• Mahesh Karande, President and Chief Executive Officer and Director
• Elliott Levy, Director
• Luke Beshar, Director

Popular executive movements at Omega Therapeutics

• Joshua Reed, Chief Financial Officer, will leave the company on May 31, 2024  (posted on April 17 2024).
• Michelle Werner has joined the company as Director  (posted on August 29 2023).
• Chris Schade has joined the company as Chairman of the Board  (posted on August 29 2023).

Click here to view some more movements at Omega Therapeutics

Create your alert
to follow the executive moves at Omega Therapeutics.

Omega Therapeutics has 2,284 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Transcarent has just announced a $126 Million fundraising (posted on May 2 2024).
• WindRose Health Investors has announced the acquisition of SubjectWell  (posted on May 2 2024).
• Enlaza Therapeutics has just announced a $100 Million fundraising (posted on May 2 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Vik Bajaj - Director at Interline Therapeutics
• Khalil Barrage - Interim Chairman of the Board at Sensorion

Learn more about the Biotechnology industry >

Press releases by Omega Therapeutics

• News Releases | Omega Therapeutics
• Events | Omega Therapeutics
• https://omegatherapeutics.com/wp-content/uploads/2019/09/Omega-Press-Release-FINAL-9.23.19.pdf
• Omega Therapeutics | Investors

Social media about Omega Therapeutics

• Omega Therapeutics on Wikipedia, Google News & Yahoo Finance
• Omega Therapeutics on LinkedIn, Twitter & YouTube

Contact by email its executives including Mahesh Karande

Call Omega Therapeutics at +1 617...

View the org chart

Register to receive your alert

Report an error